Works matching IS 02780232 AND DT 2007 AND VI 25 AND IP 3

Results: 9

Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.

Published in:

Hematological Oncology, 2007, v. 25, n. 3, p. 127, doi. 10.1002/hon.820

By:

Kalpadakis, C;
Pangalis, GA;
Dimopoulou, MN;
Vassilakopoulos, TP;
Kyrtsonis, M-C;
Korkolopoulou, P;
Kontopidou, FN;
Siakantaris, MP;
Dimitriadou, EM;
Kokoris, SI;
Tsaftaridis, P;
Plata, E;
Angelopoulou, MK

Publication type:

Article

Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with Essential Thrombocythemia.

Published in:

Hematological Oncology, 2007, v. 25, n. 3, p. 115, doi. 10.1002/hon.816

By:

Radaelli, Franca;
Colombi, Mariangela;
Calori, Rossella;
Zilioli, Vittorio Ruggero;
Bramanti, Stefania;
Iurlo, Alessandra;
Zanella, Alberto

Publication type:

Article

Phase II study of CLAD (cyclophosphamide, liposomal doxorubicin and dexamethasone) in patients with advanced multiple myeloma and historical comparison to CAD (cyclophosphamide, doxorubicin and dexamethasone)

Published in:

2007

By:

Hütter G;
Szélenyi H;
Schmittel A;
Siehl JM;
Thiel E;
Keilholz U

Publication type:

Journal Article

Prognostic relevance of circulating matrix metalloproteinase-2 in acute myeloid leukaemia patients.

Published in:

Hematological Oncology, 2007, v. 25, n. 3, p. 121, doi. 10.1002/hon.817

By:

Aref, Salah;
Osman, E.;
Mansy, S.;
Omer, N.;
Azmy, E.;
Goda, T.;
El-Sherbiny, M.

Publication type:

Article

Current Awareness in Hematological Oncology.

Published in:: Hematological Oncology, 2007, v. 25, n. 3, p. 148, doi. 10.1002/hon.797
Publication type:: Article

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.

Published in:

Hematological Oncology, 2007, v. 25, n. 3, p. 143, doi. 10.1002/hon.822

By:

Andrikovics, Hajnalka;
Nahajevszky, Sarolta;
Szilvási, Anikó;
Bors, András;
Ádám, Emma;
Kozma, András;
Kajtár, Béla;
Barta, Anikó;
Poros, Anna;
Tordai, Attila

Publication type:

Article

A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma.

Published in:

Hematological Oncology, 2007, v. 25, n. 3, p. 107, doi. 10.1002/hon.815

By:

Tsurumi, Hisashi;
Hara, Takeshi;
Goto, Naoe;
Kanemura, Nobuhiro;
Kasahara, Senji;
Sawada, Michio;
Yasuda, Ichiro;
Yamada, Toshiki;
Shimizu, Masahito;
Takami, Tsuyoshi;
Moriwaki, Hisataka

Publication type:

Article

Phase II study of CLAD (cyclophosphamide, liposomal doxorubicin and dexamethasone) in patients with advanced multiple myeloma and historical comparison to CAD (cyclophosphamide, doxorubicin and dexamethasone).

Published in:

Hematological Oncology, 2007, v. 25, n. 3, p. 132, doi. 10.1002/hon.821

By:

Hütter, G.;
Szélenyi, H.;
Schmittel, A.;
Siehl, J. M.;
Thiel, E.;
Keilholz, U.

Publication type:

Article

Senile EBV-associated B-cell lymphoproliferative disorder of prepatellar bursa in an elderly patient with multifocal urate arthropathy.

Published in:

Hematological Oncology, 2007, v. 25, n. 3, p. 140, doi. 10.1002/hon.814

By:

Mueller, Susanna;
Aigner, Thomas;
Haag, Jochen;
Schwarz, Rene;
Niedobitek, Gerald

Publication type:

Article